Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial

被引：0
|
作者：
Bartolomé R. Celli
Marc Decramer
Dacheng Liu
Norbert Metzdorf
Guus M. Asijee
Donald P. Tashkin
机构：
[1] Brigham and Women’s Hospital,Pulmonary Division
[2] University of Leuven,undefined
[3] Boehringer Ingelheim Pharmaceuticals Inc,undefined
[4] Boehringer Ingelheim Pharma GmbH & Co. KG,undefined
[5] David Geffen School of Medicine UCLA,undefined
来源：
Respiratory Research | / 17卷
关键词：
Exacerbation; COPD; Mortality; Composite endpoint; Outcomes; Discontinuation; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The Bexagliflozin Efficacy and Safety Trial (BEST): A Randomized, Double-Blind, Placebo-Controlled, Phase IIII, Clinical Trial
    McMurray, John J. V.
    Freeman, Mason W.
    Massaro, Joe
    Solomon, Scott
    Lock, Paul
    Riddle, Matthew C.
    Halvorsen, Yuan-Di C.
    DIABETES, 2020, 69
  • [42] Patient expectations in placebo-controlled randomized clinical trials
    Stone, DA
    Kerr, CE
    Jacobson, E
    Conboy, LA
    Kaptchuk, TJ
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2005, 11 (01) : 77 - 84
  • [43] Efficacy of lofexidine for mitigating opioid withdrawal symptoms: results from two randomized, placebo-controlled trials
    Alam, Danesh
    Tirado, Carlos
    Pirner, Mark
    Clinch, Thomas
    JOURNAL OF DRUG ASSESSMENT, 2020, 9 (01) : 13 - 19
  • [44] Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)
    Nash, Peter
    Mease, Philip J.
    McInnes, Iain B.
    Rahman, Proton
    Ritchlin, Christopher T.
    Blanco, Ricardo
    Dokoupilova, Eva
    Andersson, Mats
    Kajekar, Radhika
    Mpofu, Shephard
    Pricop, Luminita
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [45] Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)
    Peter Nash
    Philip J. Mease
    Iain B. McInnes
    Proton Rahman
    Christopher T. Ritchlin
    Ricardo Blanco
    Eva Dokoupilova
    Mats Andersson
    Radhika Kajekar
    Shephard Mpofu
    Luminita Pricop
    Arthritis Research & Therapy, 20
  • [46] Efficacy and Safety of Vardenafil for the Treatment of Erectile Dysfunction in Men with Metabolic Syndrome: Results of a Randomized, Placebo-Controlled Trial
    Schneider, Tim
    Gleissner, Jochen
    Merfort, Frank
    Hermanns, Monika
    Beneke, Manfred
    Ulbrich, Ernst
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 (10): : 2904 - 2911
  • [47] Efficacy and Safety of Topical WBI-1001 in the Treatment of Atopic Dermatitis: Results From a Phase 2A, Randomized, Placebo-Controlled Clinical Trial
    Bissonnette, Robert
    Chen, Genhui
    Bolduc, Chantal
    Maari, Catherine
    Lyle, Michael
    Tang, Liren
    Webster, John
    Zhou, Youwen
    ARCHIVES OF DERMATOLOGY, 2010, 146 (04) : 446 - 449
  • [48] EFFICACY AND SAFETY OF VARDENAFIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN MEN WITH METABOLIC SYNDROME: RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Schneider, T.
    Gleissner, J.
    Merfort, F.
    Hermanns, M.
    Beneke, M.
    Ulbrich, E.
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 438 - 438
  • [49] Antidepressant efficacy of the antimuscarinic drug scopolamine - A randomized, placebo-controlled clinical trial
    Furey, Maura L.
    Drevets, Wayne C.
    ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (10) : 1121 - 1129
  • [50] Efficacy and safety of Actovegin in the treatment of intermittent claudication: results of an international, multicenter, placebo-controlled, randomized, phase IIIb clinical trial (APOLLO)
    Suchkov, Igor A.
    Mzhavanadze, Nina D.
    Bogachev, Vadim Y.
    Bokuchava, Mamuka
    Kuznetsov, Maxim R.
    V. Lukyanov, Yury
    Kelimbetov, Rustambek
    Pang, Hang
    Araslanov, Sergey A.
    INTERNATIONAL ANGIOLOGY, 2022, 41 (05) : 405 - 412
12345